Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Parambir Dulai, MD, describes how vedoluzimab works, the design of the VICTORY study, and provides tips for using this agent for ulcerative colitis patients. (11:24)
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"American Journal of Gastroenterology Author Podcasts","authorlink":""},"src":"http:\/\/s3.gi.org\/podcasts\/ajg\/AJGPodcastDulai.mp3","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202311\/886bed-d1d1-62e9-8c7511_800.png"},"title":"Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium","link":"javascript:;","id":"item-680863"}]
